Abstract:Objective To evaluate the feasibility of transarterial prostate embolization for reducing the volume and its technical safety in hormone-induced dogs prostate hyperplasia.Methods Prostate hyperplasia was induced on 12 adult male dogs by administering testosterone propionate for 12 weeks.Then,the dogs were randomly assigned to transarterial prostatic embolization group (n =6) and control group (n =6).Twelve weeks after initiating the hormone treatment,6 animals in transarterial prostatic embolization group underwent prostatic arterial embolization with Embospheres 100-300 μm in diameter.Based on MRI,the volume of prostate was measured for both groups on the three time points:before injection of hormone (BI),before the procedure of prostatic arterial embolization (BP) and 12 weeks after the procedure of prostatic arterial embolization (AP).Finally,the prostates and surrounding tissues were harvested for histopathology study.A statistical software package (SPSS version 19.0) was used for analysis.Measurement data were expressed as x-± s.Samples paired t test was used to compare the prostatic volume between BP and AP.The t test was applied in the intergroup comparison.P ＜ 0.05 was considered to indicate a statistically significant difference.Results The successful rate of BPH model establishment and superselective catheterization were 100％.No serious procedure-related complication was observed.After 12 weeks of hormone administration,the mean volume of prostate was 19.5 ± 2.5 mm3 in embolization group and 19.2 ±3.8 mm3 in control group before prostatic arterial embolization,without statistical difference(t =0.14,P ＞0.05).At 12 weeks after prostatic arterial embolization,the mean volume of prostate was 6.1 ± 1.4 mm3 in embolization group and 17.8 ± 3.5 mm3 in control group with significant statistical difference (t =-7.6,P ＜ 0.05).Compared with pretreatment measurement,the mean volume of prostate decreased by 68.7％ at 12 weeks after prostatic arterial embolization with significant statistical difference (t =10.7,P ＜ 0.05).But there was no statistical difference between the two time points in control group with a 7.3％ mean decrease (t =1.4,P ＞0.05).Histopathology study revealed that embosphere particles had occluded partial arterioles of the prostate in the embolization group of dogs.Near the occluded arterioles,normal gland structure disappeared; while residual gland tissue appeared to be atrophied.In embolization group,there was no gross or microscopic change in the surrounding tissues including bladder,deferent duct and rectum.Extensive prostate glandular hyperplasia was observed in control group.Conclusions Transcatheter arterial embolization is feasible for reducing prostate volume without serious complication in hormone-induced prostate hyperplasia dogs and worthy of further investigation.

Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia

[Effect of Electrovaporization on the Prostate and Its Surrounding Tissues].

PD10-12 WATER II: AQUABLATION THERAPY FOR BENIGN PROSTATIC HYPERPLASIA IN MEN WITH LARGE PROSTATES (80-150CC) 6-MONTH SAFETY AND EFFICACY RESULTS

Ablation of Canine Prostate Using Two-Stage Intraprostatic Hot Agarose Solution and Enzyme Injection

Contrast Enhanced Ultrasound For Radio Frequency Ablation Of Canine Prostates: Initial Results

Safety And Feasibility Of Prostatic Tissue Ablation In Dogs By Percutaneous Irreversible Electroporation (Ire) Using A Newly-Developed High-Voltage Steep-Pulse-Therapy Device

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation

Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models

Safety and Efficacy of Same Day Discharge for Men Undergoing Contemporary Robotic-Assisted Aquablation Prostate Surgery in an Ambulatory Surgery Center Setting – First Global Experience

0216: Contrast US-Guided RF Ablation of Prostate: Laboratory and Clinical Experiences

The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia

Effect of Acoustically Responsive Droplet-based Low-intensity Histotripsy on Canine Prostate

Evaluation of safety and efficacy of insulated-gate bipolar transistor holmium laser technology for prostate enucleation in canine model: a preliminary study

AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population

Development of a Novel Robot for Transperineal Needle Based Interventions: Focal Therapy, Brachytherapy and Prostate Biopsies

Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology

Robot-assisted radical prostatectomy using the avatera system™: a prospective pilot study

Biocompatibility and Efficacy of Prostatic Urethral Lift in Benign Prostate Hyperplasia: an in Vivo and in Vitro Study

Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial

Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy

Transarterial Prostatic Embolization: Initial Experience in Hormone-Induced Benign Prostatic Hyperplasia in Dogs